D
D. Vidyadhari
Researcher at MediCiti Institute of Medical Sciences
Publications - 4
Citations - 1305
D. Vidyadhari is an academic researcher from MediCiti Institute of Medical Sciences. The author has contributed to research in topics: Premature birth & Placebo-controlled study. The author has an hindex of 4, co-authored 4 publications receiving 1217 citations.
Papers
More filters
Journal ArticleDOI
Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial
Sonia S. Hassan,Sonia S. Hassan,Roberto Romero,Roberto Romero,Roberto Romero,D. Vidyadhari,S. Fusey,Jason K. Baxter,Meena Khandelwal,J. Vijayaraghavan,Y. Trivedi,Priya Soma-Pillay,P. Sambarey,Ashlesha K. Dayal,V. Potapov,John M. O'Brien,John M. O'Brien,V. Astakhov,O. Yuzko,W. Kinzler,B. Dattel,H. Sehdev,L. Mazheika,D. Manchulenko,M. T. Gervasi,Lisa M. Sullivan,Agustin Conde-Agudelo,James A. Phillips,George W. Creasy +28 more
TL;DR: The efficacy and safety of using micronized vaginal progesterone gel to reduce the risk of preterm birth and associated neonatal complications in women with a sonographic short cervix is determined.
Journal ArticleDOI
Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double‐blind, placebo‐controlled trial
John M. O'Brien,Charles Adair,David F. Lewis,David Hall,Emily DeFranco,S. Fusey,Priya Soma-Pillay,Kathy B. Porter,Helen How,R. Schackis,D. Eller,Y. Trivedi,G. Vanburen,Meena Khandelwal,Kenneth F. Trofatter,D. Vidyadhari,J. Vijayaraghavan,J. Weeks,B. Dattel,E. Newton,C. Chazotte,G. Valenzuela,Pavel Calda,M. Bsharat,George W. Creasy +24 more
TL;DR: The objective of this trial was to determine whether prophylactic administration of vaginal progesterone reduces the risk of preterm birth in women with a history of spontaneous pre term birth.
Journal ArticleDOI
Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix : a secondary analysis from a randomized, double-blind, placebo-controlled trial
Emily DeFranco,John M. O'Brien,Charles Adair,David F. Lewis,David Hall,S. Fusey,Priya Soma-Pillay,Kathy B. Porter,Helen How,R. Schakis,D. Eller,Y. Trivedi,G. Vanburen,Meena Khandelwal,Kenneth F. Trofatter,D. Vidyadhari,J. Vijayaraghavan,J. Weeks,B. Dattel,E. Newton,C. Chazotte,G. Valenzuela,Pavel Calda,M. Bsharat,George W. Creasy +24 more
TL;DR: To investigate the efficacy of vaginal progesterone to prevent early preterm birth in women with sonographic evidence of a short cervical length in the midtrimester, a large number of studies have found it to be safe and effective.
Journal ArticleDOI
Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: A multicenter, randomized, double-blind, placebo-controlled trial
Sonia S. Hassan,Sonia S. Hassan,Roberto Romero,Roberto Romero,Roberto Romero,D. Vidyadhari,S. Fusey,Jason K. Baxter,Meena Khandelwal,J. Vijayaraghavan,Y. Trivedi,Priya Soma-Pillay,P. Sambarey,Ashlesha K. Dayal,V. Potapov,John M. O'Brien,John M. O'Brien,V. Astakhov,O. Yuzko,W. Kinzler,B. Dattel,H. Sehdev,L. Mazheika,D. Manchulenko,M. T. Gervasi,Lisa M. Sullivan,Agustin Conde-Agudelo,James A. Phillips,George W. Creasy +28 more
TL;DR: The efficacy and safety of using micronized vaginal progesterone gel to reduce the risk of preterm birth and associated neonatal complications in women with a sonographic short cervix is determined.